Cargando…
ERRα activates SHMT2 transcription to enhance the resistance of breast cancer to lapatinib via modulating the mitochondrial metabolic adaption
Lapatinib, a tyrosine kinase inhibitor, can initially benefit the patients with breast tumors but fails in later treatment due to the inevitable development of drug resistance. Estrogen-related receptor α (ERRα) modulates the metabolic adaptations in lapatinib-resistant cancer cells; however, the un...
Autores principales: | Li, Xin, Zhang, Kejing, Hu, Yu, Luo, Na |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970080/ https://www.ncbi.nlm.nih.gov/pubmed/31894856 http://dx.doi.org/10.1042/BSR20192465 |
Ejemplares similares
-
ERRα mediates metabolic adaptations driving lapatinib resistance in breast cancer
por: Deblois, Geneviève, et al.
Publicado: (2016) -
Glycyrrhetinic acid restricts mitochondrial energy metabolism by targeting SHMT2
por: Jin, Xiuxiu, et al.
Publicado: (2022) -
ERRα as a Bridge Between Transcription and Function: Role in Liver Metabolism and Disease
por: Xia, Hui, et al.
Publicado: (2019) -
PERM1 regulates energy metabolism in the heart via ERRα/PGC−1α axis
por: Oka, Shin-ichi, et al.
Publicado: (2022) -
SHMT1 and SHMT2 Are Functionally Redundant in Nuclear De novo Thymidylate Biosynthesis
por: Anderson, Donald D., et al.
Publicado: (2009)